Lexapro side effects like persistent pulmonary hypertension in newborns (PPHN) and other birth defects may occur if the mother took this drug during pregnancy. We are currently working with some of the more experienced dangerous drug attorneys who can file a Lexapro lawsuit on your behalf and charge no legal fees unless you receive a settlement or award. Contact us for a free consultation online or call us toll-free at 1-800-992-6878.
Have You or Your Newborn Suffered Any Serious Side Effects Due to Lexapro?
Call Us Today! at 1-800-992-6878
Lexapro Side Effects
Like all drugs, this antidepressant has the potential to cause a variety of side effects. Among the less serious side effects are: sleep problems, weight changes, and nausea. More serious side effects include: birth defects, serotonin syndrome, and suicidal behavior.
Lexapro Birth Defects and FDA Warnings
In 2006, the FDA issued a birth defect warning for all SSRI antidepressants, including Lexapro. The warning stated that this class of antidepressants had been linked to persistent pulmonary hypertension in newborns (PPHN) as revealed by a study in New England Medical Journal. The study found that mothers who took drugs such as this antidepressant during pregnancy were six times more likely to give birth to a baby with PPHN (i).
Other medical studies have found a link between SSRIs and heart birth defects. For example, in September 2009, the British Medical Journal published a study which found that “there is an increased prevalence of septal heart defects among children whose mothers were prescribed an SSRI in early pregnancy (ii).” Additionally, in March 2010, the Journal of Clinical Epidemiology published a study which found that there was “an association between maternal SSRI use in early pregnancy and cardiac malformations (iii).” You should talk to a personal injury lawyer if you took this medication during pregnancy and your child was born with any of the following birth defects:
- Abdominal birth defects<
- Cleft lip or palate
- Down’s syndrome
- Hypoplastic Left/Right Heart Syndrome
- Persistent Pulmonary Hypertension (PPHN)
- Septal heart defects (atrial or ventricular)
- Spina bifida
- Or any other birth defects
Lexapro Suicide Risk
Of the 6,184 primary suspect adverse event reports the FDA has received, there were over 400 cases of suicidal behavior with over 350 completed suicides (iv). The FDA has issued many warnings about the link between SSRI use and suicidal behavior. The first warning was issued in 2004 and the FDA required all SSRI manufacturers to include a new black box warning on their drug labels. This warning stated that antidepressants such as this one may increase the risk of suicidal behavior in children and teenagers. After reviewing 295 medical studies with over 77,000 participants, the FDA decided to expand its suicide warning in 2007. The new warning stated that the increased risk of suicidal behavior was present in young adults up to age of 24 (v).
Lawsuits Against the Manufacturer
Forest Laboratories has paid a large settlement and now faces a number of lawsuits related to this drug. In September 2010, the company reached a $313 million dollar settlement with the U.S. Department of Justice for civil and criminal allegations. The settlement was paid because Forest Laboratories had been illegally marketing its drugs Celexa and Lexapro, among others, for off-label uses (vi). Most recently, in Forest Laboratories’ 2012 annual report, the company stated that it is defending 93 product liability lawsuits related to those two drugs alone. Of these lawsuits, there are 14 Lexapro suicide lawsuits and 79 Lexapro birth defects lawsuits. A large number of the birth defect lawsuits allege that these medications were the cause of PPHN (vii).
Contact the Law Offices of d’Oliveira & Associates
If you or a loved one has suffered birth defects or other side effects as a result of taking Lexapro, you may be entitled to compensation. Our law firm is currently working with some of the more experienced Lexapro attorneys in the country who are handling these cases and charge no legal fees unless you receive a settlement or award.
Feel free to d’Oliveira & Associates at 1-800-992-6878 or fill out a contact form for a free consultation.
- (i) FDA Public Health Advisory, July 2006.
- (ii) British Medical Journal, September 2009.
- (iii) Clinical Epidemiogolgy, March 2010.
- (iv) Adverse Events, August 2012.
- (v) FDA Drug Safety Information, May 2007.
- (vi) The New York Times, September 2010.
- (vii) Forest Laboratories 2012 Annual Report.